Comparison of ondansetron and droperidol in the prevention of postoperative nausea and vomiting after laparoscopic surgery in women. A randomised, double-blind, placebo-controlled trial

Acta Anaesthesiologica Scandinavica
M KoivurantaS Alahuhta

Abstract

Women undergoing laparoscopic surgery are susceptible to postoperative nausea and vomiting (PONV). Ondansetron and droperidol are useful antiemetics. This study was designed to ascertain primarily the relative difference in efficacy of ondansetron and droperidol and secondarily between these drugs and placebo in the prevention of PONV after laparoscopic surgery. The prophylactic antiemetic efficacy of ondansetron and droperidol was compared in a prospective, randomised, double-blind, placebo-controlled trial of 439 female inpatients scheduled for laparoscopic surgery. During induction of standardised general anaesthesia the patients received intravenously either ondansetron 8 mg (n=195), droperidol 1.25 mg (n=193) or placebo (n=51). The occurrence of nausea, vomiting, side-effects and the need for rescue antiemetic medication were recorded for 24 h postoperatively. The proportion of patients with nausea was 48%, 50% and 67% in the ondansetron, droperidol and placebo groups, respectively; with a significant difference when both ondansetron (P=0.02) and droperidol (P=0.04) were compared with placebo. Vomiting occurred in 18%, 26% and 37% of the patients in the three groups, respectively (P=0.05 between ondansetron and droperidol,...Continue Reading

References

Jan 1, 1992·British Journal of Anaesthesia·K Korttila
Jan 1, 1992·British Journal of Anaesthesia·J Lerman
Jan 1, 1992·British Journal of Anaesthesia·D J Rowbotham
Jan 1, 1995·Paediatric Anaesthesia·R J Mawer, P M Spargo
Nov 1, 1994·Anesthesia and Analgesia·S N KhalilI Gilmour
Dec 1, 1993·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·J H HelmersK Hellstern

❮ Previous
Next ❯

Citations

Jun 30, 2000·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·I HenziM R Tramèr
Oct 14, 2000·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·P S LoewenP J Zed
Jan 1, 2008·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Grigori SmirnovHannu Kokki
May 29, 1998·Journal of Clinical Anesthesia·E D Figueredo, L G Canosa
Feb 11, 2000·Acta Anaesthesiologica Scandinavica·E HagemannJ C Raeder
Oct 24, 2003·International Anesthesiology Clinics·Johan Raeder
Apr 11, 2009·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Yoshitaka Fujii, Michiyo Itakura
Sep 29, 2007·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Y Fujii, M Nakayama
Nov 14, 2006·Acta Anaesthesiologica Scandinavica·J RaederJ Kilhamn
Mar 7, 2006·Journal of Clinical Anesthesia·Sinikka PurhonenMarkku Hynynen
Apr 2, 2003·Expert Opinion on Pharmacotherapy·Ashraf S Habib, Tong J Gan
Dec 3, 1999·European Journal of Anaesthesiology·L PapadimitriouJ Papadimitriou
Apr 23, 2005·Surgical Innovation·Aaron Goldfaden, John D Birkmeyer
Feb 18, 2009·Journal of Gastroenterology and Hepatology·Toru HiyamaKazuaki Chayama
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Asbjørn Hróbjartsson, Peter C Gøtzsche
Jul 18, 2017·The Cochrane Database of Systematic Reviews·John Carlisle, Carl A Stevenson
Oct 20, 2020·The Cochrane Database of Systematic Reviews·Stephanie WeibelPeter Kranke
Feb 24, 2001·Gastroenterology·E M QuigleyH P Parkman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.